Browsing: Ozempic
Special menus with petite, less expensive portions are popping up all over, from large chains like Olive Garden and The…
For the first time ever, the World Health Organization has issued global guidance on the use of GLP-1 drugs for…
Gallup released a survey this week showing that the obesity rate among US adults has fallen to 37% this year, a significant…
In today’s edition: Jane Fraser’s meeting with Trump, some dark horse candidates for Fed chair, and a startup pivot that…
Glucagon-Like-Peptide-1 Agonists, like Ozempic, have become extremely popular for weight loss. In fact, about 1 in 8 Americans have taken…
You could say that taking Ozempic and other glucagon-like peptide-1 agonists for weight loss has been a growing trend. But…
When Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen dialed into a Teams video call with Chairman Helge Lund,…
You may have heard of “Ozempic face”, “Ozempic butt” and “Ozempic finger,” three things that I have written about previously…
In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the…
Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is quickly emerging as…